Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

BioArctic receives patent in Japan for new antibodies targeting Parkinson’s disease

Stockholm, August 23, 2023 – BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) announced today that the Japanese Patent Office (JPO) is granting a new drug substance patent for the antibody BAN0805, invented by BioArctic as a potential treatment of Parkinson’s disease. The patent will expire in 2041, with the possibility of a patent term extension up until 2046.The granted substance patent (based on Japanese patent application no. 2021-570377) focuses on the monoclonal antibody BAN0805, which selectively binds to and eliminates pathological aggregated forms called oligomers and protofibrils

Rebuilt Vildmannen 7 officially opened

An official opening ceremony was held for the rebuilt Vildmannen 7 building on August 23 in Stockholm. Located at the intersection of Biblioteksgatan and Jakobsbergsgatan, this grand 19th century building is again being filled with life and activity as the first tenants move into these modern and multi-purpose premises.Following an impressive and complex construction process, Vildmannen 7 is once again bringing its lustre to Bibliotekstan in Stockholm. In November 2017, a devastating fire came close to completely destroying this culturally and historically significant building. However, the

Civil lawsuit in Korea resolved

The civil lawsuit regarding administrative costs initiated by the Korean subsidiary in Ulsan in 2017 have been resolved in favour of Ulsan City. The ruling will not impact the financial result as the costs already have been accounted for in their entirety. The company has yet to decide whether to appeal further.As previously reported, the Korean subsidiary initiated legal proceedings in 2017 regarding certain administrative costs Ulsan City invoiced the company. The court has previously ruled these costs not to be subject to administrative law leading to the civil lawsuit. The first

Nordic Mining ASA: MoU for cooperation on utilization of tailings from Engebø Rutile and Garnet

Nordic Mining ASA (“Nordic Mining” or the “Company”) is pleased to announce that the Company, through its wholly-owned subsidiary Engebø Rutile and Garnet AS, has entered into a Memorandum of Understanding (“MoU”) with Saferock AS (“Saferock”). The MoU is for a joint product development project on applicability of residual mineral streams from Nordic Mining’s Engebø Rutile and Garnet project in production of cement binders. Saferock is a Norwegian technology company developing a product that may reduce carbon emissions from the concrete industry and utilize residual minerals from the

DEVERSIFY’S BREATHALYSER ACETRACK INTRODUCED ON THE DUTCH MARKET

KetoFitShop, the Netherlands-based company for metabolic health products such as low- carb, keto and gluten free solutions, is partnering with the Swedish health technology company Deversify to bring the ketone breathalyser Acetrack to further European markets.Deversify specialises in breathalysers, creates educational programs around metabolic health and is world-leading in the measurement of biomarkers in exhaled air. Acetrack provides KetoFitShop with state-of-the art technology for convenient, non-invasive ketone measuring, empowering users to make informed choices for their metabolic

HydrogenPro ASA - Registration of share capital increase

Oslo, 23 August 2023: Reference is made to the stock exchange announcement published by HydrogenPro ASA ("HydrogenPro" or the "Company", ticker code: HYPRO) on 18 August 2023 regarding exercise of 271,875 options under the Company's share incentive program. Following the exercise of options, the Company's board of directors resolved on 17 August 2023 to increase the share capital by a total of NOK 5,437.5, by issuance of 271,875 new shares. The share capital increase pertaining to the issuance of shares has today been registered with the Norwegian Register of Business Enterprises.

Mer, Hubject and Driivz Demonstrate a Seamless EV Plug&Charge Experience at Intercharge Network Conference 2023

Tel Aviv/Munich, Aug. 23, 2023 – Electric vehicle (EV) drivers want a simple and seamless charging experience: drive up, plug in and charging starts automatically, without having to open an app, tap an RFID tag or use a charge card. Implementing the ISO 15118-based Plug&Charge technology makes this seamless experience a reality, as the three EV industry collaborators demonstrate at the InterCharge Network Conference (ICNC23)  in Berlin.· Mer Germany , part of the Mer Group - a leading EV charging operator in Norway, Sweden,

Invitation to Clas Ohlson’s Q1 presentation on 6 September

Clas Ohlson will publish its interim report for the first quarter 2023/24 on 6 September at 7:00 a.m. CET. A webcasted presentation of the report will be held at 9:00 a.m. CET the same day.Clas Ohlson invites investors, financial analysts and the media to a webcasted presentation of the interim report for the first quarter on Wednesday 6 September at 9:00 a.m. CET where President and CEO Kristofer Tonström and CFO Pernilla Walfridsson will comment on the report. The interim report for the period May to July 2023 will be published at 7:00 a.m. CET and the report and presentation material

SmartCraft ASA (SMCRT) - Reminder: Invitation to presentation of second quarter 2023 results and deep dive presentation

23 August 2023 - SmartCraft ASA will publish its second quarter 2023 financial report on Thursday 24 August 2023 at 07:00 CET together with the Q2 2023 presentation material on the company website and www.newsweb.no. Investors, analysts, and journalists are welcome to join to an English language webcast presentation of the report followed by a deep-dive presentation of the company's go-to-market model and development strategy on the same day, Thursday 24 August 2023, at 08:00 CET. Webcast link: https://channel.royalcast.com/landingpage/hegnarmedia/20230824_2/ Presenters: ·

BioStock: WntResearch hopes for in-depth talks about Foxy-5

Things are starting to move again for WntResearch, the company recently got the green light for its new study plan for Foxy-5. The company looks forward to being able to resume recruitment in its phase II study with the drug candidate. BioStock contacted CEO Pernilla Sandwall in connection with the release of the company’s report for the second quarter.Read the full article at biostock.se : https://www.biostock.se/en/2023/08/wntresearch-hopes-for-in-depth-talks-about-foxy-5/ This is a press release from BioStock - Connecting Innovation & Capital. https://

Notification of managers’ and closely related parties’ transactions with Dampskibsselskabet NORDEN A/S’ shares in connection with share buy-back program

ANNOUNCEMENT NO. 123 - 23 AUGUST 2023   In connection with the announced share buy-back program in NORDEN, A/S Motortramp continuously sells shares pro rata and the market is to be informed accordingly – see the attached file and announcements nos. 112/23 and 113/23.   Kind regards, Dampskibsselskabet NORDEN A/S   Martin Badsted CFO     For further information: Stig Frederiksen, Head of Investor Relations, tel.: +45 32 71 08 55, e-mail: sfr@norden.com

Exploring Autumn Delights: 5 Best Places to Walk Your Dog in Ireland

As the vibrant hues of autumn envelop Ireland, dog owners across the nation eagerly anticipate the opportunity to venture into the great outdoors with their furry companions. From captivating forests to picturesque coastal paths, Ireland offers a multitude of stunning locations perfect for autumnal dog walks. In a comprehensive guide, Dr. Orla Fitzgerald MVB MRVCS, our favourite neighbourhood vet, unveils the five best places to walk your dog in Ireland this autumn, ensuring an unforgettable experience for both you and your loyal furry friend. "Autumn in Ireland is a magical time

Marbella Town Council approves the Quartiers proposal to modify the local plan of the Centro Forestal Sueco properties

As announced in a press release on 29 May this year, Quartiers Properties AB (publ) ("Quartiers" or the "Company") has proposed an amendment to the current detailed plan for Centro Forestal Sueco. The proposal, which was developed in consultation with the Town Council and subsequently incorporated into the Town Council's Master Plan for the area, has now been unanimously approved by the Marbella Town Council. The decision significantly increases the likelihood that Quartiers will be granted 20,000 square metres of new building rights on its Marbella properties, as previously communicated.

Recipharm makes senior appointments as transition to low global warming potential propellants in pressurised Metered Dose Inhalers gains pace

Global contract development and manufacturing organisation (CDMO), Recipharm has today announced the appointment of Richard Turner as Head of Business Development, and Jeremy Tidmarsh as Site Director, Holmes Chapel, to its Advanced Delivery Systems business unit, as it continues to accelerate its ambition to supply low global warming potential (GWP) pressurised Metered Dose Inhalers (pMDIs) in response to customer demand. Richard joins Recipharm from H&T Presspart, where he was Global Sales Director. Having spent 22 years developing H&T Presspart’s pMDI components business, Richard is

Nordea Liv Norway selects Lumera for next-generation life and pensions insurance administration platform

Nordea Liv Norway is partnering with Lumera to modernize its enterprise systems for life and pensions insurance. While the Lumera platform is deployed, current legacy systems will be phased out.  Oslo, August 23, 2023 – Lumera, a leading insurtech company dedicated to the digital transformation of the European life and pensions industry, has entered an agreement with Nordic life insurance and pension provider Nordea Liv to deliver a new solution for managing the company’s life and pension insurance portfolio in the Norwegian market. Working with Lumera, Nordea Liv Norway will establish

Transcom recognized as Technology & Service Leader, powered by AI

Transcom, a global leader in digital CX solutions, has been named the 2023 Technology & Service Leader in the SPARK Matrix: Contact Center Outsourcing Services (CCOS), 2023 by Quadrant Knowledge Solutions, for the second consecutive year. The SPARK Matrix includes a detailed analysis of global market dynamics, major trends, vendor landscape, and competitive positioning. “Transcom has emerged as a comprehensive contact center outsourcing service provider. It stands out in the contact center outsourcing space with its comprehensive T:Universe suite. The company's real-time digital

The first residents are moving into Karlatornet

Construction of the tallest building in the Nordic region, Karlatornet, began at Lindholmen in Gothenburg in 2017. Now, the building is ready to welcome its first residents. On Tuesday, the first households gained access to their residences, and by summer 2024, all apartment owners are expected to have moved in.Karlatornet accommodates a total of 611 apartments, ranging from studio flats to 370-square-meter penthouse apartments. Apartments from fifth floor up to the 27th floor are now fully completed and ready to welcome the residents in tenant-owner association 1 (out of 4). Among the

Gapwaves publishes Interim Report for April – June 2023

Press release from Gapwaves AB (publ)   Gothenburg, August 23rd, 2023  Stronger interest from Automotive, in spite of slower sales The second quarter was characterized by a high level of activity, primarily in the Automotive segment where work on the contracted development of antennas for customers’ future radar sensors continued.   Strategic investment in Sensrad During the period, we took a step in a new strategic initiative by investing in Sensrad in order to assume a stronger position in radar sensors for Mobility, SmartCity and other industrial market segments.   Second

Inhalation Sciences AB (publ) to repay its loan by end of August 2023

(Stockholm, Sweden, 23 August 2023) Inhalation Sciences AB will repay a 1.8 MSEK loan which was reported in the Q1 Report 2023. The loan will be repaid by the end of August 2023. The contractual due date for repayment is December 2023. The total amount including interest and setup fee is approx. 2.6 MSEK.In the Q1 Report (31 May 2023) ISAB reported that on January 16[th], 2023 it had activated 1.8 MSEK of its credit facility, due to be repaid in December 2023. ISAB will now in advance repay the loan by the end of August 2023. The total loan amount is approx. 2.6 MSEK, including interest and

Invitation to presentation of Sectra’s three-month interim report 2023/2024

Linköping, Sweden – August 23, 2023 – International medical imaging IT and cybersecurity company Sectra  (STO: SECT B) invites investors, analysts, and the media to a presentation of the company’s three-month report with President Torbjörn Kronander and CFO Jessica Holmquist.Publication of the financial report: 8:15 a.m. (CEST) on September 5, 2023Report presentation: 10:00 a.m. (CEST) on the same date To participate, follow the instructions on Sectra’s website investor.sectra.com/q1report2324.  The broadcast will be made available on the same webpage after the

Medivir to present at the Erik Penser Bank Company Event

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announces that the company will present at the Erik Penser Bank Company Event on Thursday, August 24, 2023. CEO Jens Lindberg will present the company and its plan for the ongoing clinical study with fostroxacitabine bralpamide (fostrox) at 09.05 CET.  The presentation will be available after the meeting on Medivirs website; www.medivir.com.   For additional information, please contact;Magnus Christensen,

Episurf Medical: First commercial case in the US scheduled

Episurf Medical (Nasdaq: EPIS B) today announces that the company’s first commercial case in the US has been scheduled for surgery. This is also the first case ever with the newly introduced product Episealer® Patellofemoral System. The product is a fully individualized implant system for patients with isolated osteoarthritis of the patellofemoral joint in the knee. Personalized implants for both sides of the joint, femur and patella, preserving as much bone and cartilage as possible by treating only the damaged areas of the joint, are designed uniquely for each individual patient. 510(k)

There are no items matching the current filter
There are no more items matching the current filter
Back to top